Physician
Rosenman, Michael
Rosenman, Michael was paid $4.72M by Medicaid between Jan 2018 and Dec 2024, across 76 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 16% of everything it billed.
33Billing provider infoROSENMAN, MICHAEL
LAS VEGAS, NV 89109
LAS VEGAS, NV 89109
33aNPI1427140615assigned 09/28/2006
33bProvider typePediatrics Physician
28Total paid$4.72M
24GClaims153,054
24DCodes billed76
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Nevada
Rank by total paid#9 of 267
Median peer was paid$116K
This provider vs. median41×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,135 | $640K | |
| 2019 | 21,693 | $609K | |
| 2020 | 21,504 | $642K | |
| 2021 | 25,323 | $787K | |
| 2022 | 25,837 | $812K | |
| 2023 | 22,691 | $734K | |
| 2024incomplete | 14,871 | $492K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 12,619 | 10,809 | $776K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 15% | 12,219 | 11,369 | $718K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 14% | 7,417 | 5,975 | $673K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 13% | 6,416 | 6,009 | $610K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 5,803 | 5,088 | $556K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.5% | 3,850 | 3,637 | $355K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.9% | 1,831 | 1,707 | $183K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 3.1% | 6,254 | 5,922 | $146K |
| 99188 | 2.8% | 11,948 | 11,179 | $134K | |
| 99058 | 1.7% | 4,927 | 4,441 | $79K | |
| 99253 | 1.5% | 860 | 769 | $73K | |
| 94010 | 1.2% | 1,992 | 1,683 | $59K |
64 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 3,143 | $51K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.0% | 5,874 | $48K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,179 | $43K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,188 | $24K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 958 | $18K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,270 | $17K |
| 94760 | <1% | 8,146 | $17K | |
| 99383 | <1% | 169 | $17K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,005 | $14K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 629 | $14K |
| 94667 | <1% | 544 | $12K | |
| 99463 | <1% | 489 | $11K | |
| 99401 | <1% | 348 | $10K | |
| 87807 | <1% | 1,087 | $8K | |
| 92552 | <1% | 471 | $7K | |
| 86580 | <1% | 1,147 | $5K | |
| 92015 | Determination of refractive state | <1% | 688 | $5K |
| 99384 | <1% | 42 | $5K | |
| 92567 | <1% | 315 | $4K | |
| 81002 | <1% | 3,178 | $4K | |
| 96127 | <1% | 645 | $3K | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 1,260 | $3K |
| 85018 | <1% | 1,703 | $2K | |
| 36416 | <1% | 1,760 | $2K | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 1,239 | $2K |
| 99382 | <1% | 13 | $1K | |
| 99381 | <1% | 13 | $1K | |
| 84030 | <1% | 686 | $1K | |
| 94761 | <1% | 286 | $730.62 | |
| 90700 | <1% | 4,972 | $622.74 | |
| J7633 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram | <1% | 384 | $601.67 |
| 93000 | <1% | 41 | $597.89 | |
| 90713 | <1% | 4,123 | $327.26 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 110 | $297.05 |
| 92587 | <1% | 28 | $252.20 | |
| A4250 | Urine test or reagent strips or tablets (100 tablets or strips) | <1% | 174 | $123.90 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 41 | $78.20 |
| 90671 | <1% | 847 | $68.70 | |
| 90647 | <1% | 1,213 | $66.10 | |
| J7610 | Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg | <1% | 926 | $64.12 |
| 94729 | <1% | 15 | $50.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 306 | $49.28 |
| 90648 | <1% | 2,632 | $44.05 | |
| A6203 | Composite dressing, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing | <1% | 19 | $7.44 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 212 | $5.31 |
| 90651 | <1% | 645 | $0.39 | |
| 90686 | <1% | 3,517 | $0.03 | |
| 90619 | <1% | 131 | $0.03 | |
| 90680 | <1% | 2,809 | $0.01 | |
| 90744 | <1% | 2,346 | $0.01 | |
| 90716 | <1% | 1,736 | $0.01 | |
| 90670 | <1% | 3,107 | $0.01 | |
| 90715 | <1% | 111 | $0.01 | |
| 97802 | 0% | 115 | $0.00 | |
| 99000 | 0% | 1,028 | $0.00 | |
| 90657 | 0% | 359 | $0.00 | |
| 2015F | 0% | 30 | $0.00 | |
| 2016F | 0% | 12 | $0.00 | |
| 90633 | 0% | 1,995 | $0.00 | |
| 90707 | 0% | 1,791 | $0.00 | |
| 90658 | 0% | 396 | $0.00 | |
| 90734 | 0% | 213 | $0.00 | |
| 90710 | 0% | 29 | $0.00 | |
| 1039F | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.